Results 151 to 160 of about 38,316 (246)

Elimination of tumor by CD47/PD-L1 dual-targeting fusion protein that engages innate and adaptive immune responses

, 2017
Boning Liu, Huaizu Guo, Jin Xu, Ting Qin, Qingcheng Guo, Nana Gu, Dapeng Zhang, Weizhu Qian, Jianxin Dai, Sheng Hou, Hao Wang, Yajun Guo   +11 more
openalex   +1 more source

Activated CD47 promotes pulmonary arterial hypertension through targeting caveolin-1 [PDF]

, 2012
Philip M. Bauer, Eileen Bauer, Natasha M. Rogers, Mingyi Yao, Mónica Feijoo‐Cuaresma, Joseph M. Pilewski, Hunter C. Champion, Brian S. Zuckerbraun, Marı́a J. Calzada, Jeffrey S. Isenberg   +9 more
openalex   +1 more source

Diazirines Beyond Photoaffinity Labeling: A Comprehensive Overview of Applications in Biological Sciences, Materials Chemistry, and NMR‐Spectroscopy

Angewandte Chemie, Volume 138, Issue 4, 22 January 2026.
Diazirines are three‐membered, nitrogen‐containing heterocycles that decompose under light or heat to generate carbenes. For the past two decades, they have served mainly as minimally invasive tags in photoaffinity labeling (PAL). More recently, their value as versatile carbene precursors has been recognized.
Dominik Schnalzer, Viktor Savic, Clemens Cziegler, Michael Schnürch, Marko D. Mihovilovic   +4 more
wiley   +2 more sources

Absence of CD47 in protein 4.2-deficient hereditary spherocytosis in man: an interaction between the Rh complex and the band 3 complex [PDF]

, 2002
Lesley J. Bruce
openalex   +1 more source

Supplementary figure legend from Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms

, 2023
Michele Cioffi, Sara Maria David Trabulo, Manuel Hidalgo, Eithne Costello, William Greenhalf, Mert Erkan, Jörg Kleeff, Bruno Sáinz, Christopher Heeschen   +8 more
openalex   +1 more source

Targeting aerobic glycolysis combats tyrosine kinase inhibitor resistance of hepatocellular carcinoma

International Journal of Cancer, Volume 158, Issue 3, Page 475-487, 1 February 2026.
Abstract Hepatocellular carcinoma (HCC) represents the predominant form of primary liver cancer and is frequently identified at a late stage, necessitating systemic therapy. However, resistance to first‐line tyrosine kinase inhibitor therapies, such as sorafenib and lenvatinib, remains a significant clinical challenge.
Longtao Zhao, Junjie Cheng, Yiming Zheng, Jing Wu, Jia Fan, Haixiang Sun, Chao Gao   +6 more
wiley   +1 more source

Hypoxia-induced ZEB1 promotes cervical cancer immune evasion by strengthening the CD47-SIRPα axis [PDF]

Xiaojing Chen, Chu-Hong Guo, Zi‐Ci Wang, Yang Yang, Yu-Hua Pan, Jieying Liang, Mei-Ge Sun, Liangsheng Fan, Liang Li, Wei Wang   +9 more
openalex   +1 more source

A Dually Nanobody‐Engineered Milk‐Derived Extracellular Vesicle Nanomedicine Targeting Tumour‐Associated Macrophages and Cancer Cells for Cancer Therapy

Journal of Extracellular Vesicles, Volume 15, Issue 2, February 2026.
ABSTRACT Tumour development and progression are driven by intricate interactions among various cell types within the tumour microenvironment (TME). Targeting a single cell type often fails to eradicate cancer, highlighting the need for strategies to co‐target multiple cell types.
Zhiang Liu, Ying Chen, Yulin Cao, Yanchao Zhang, Yuanben Wang, Han Cheng, Junhui Tang, Haofei Hong, Yuyang Feng, Surui Yao, Zehua Bian, Yuan Yin, Kaisa Cui, Zhimeng Wu, Zhaohui Huang   +14 more
wiley   +1 more source

Tumor Immunotherapy and Microbiome: From Bench‐to‐Bedside Applications

MedComm, Volume 7, Issue 2, February 2026.
The microbiome is related to the efficacy of immunotherapy and can be utilized to predict the efficacy and adverse reactions of immunotherapy. Microbiome‐targeted intervention strategies can improve the efficacy of ICI, but necessitating more comprehensive exploration.
Anqi Lin, Minying Xiong, Aimin Jiang, Li Chen, Lihaoyun Huang, Kailai Li, Hank Z. H. Wong, Jian Zhang, Zaoqu Liu, Quan Cheng, Bufu Tang, Pengpeng Zhang, Peng Luo   +12 more
wiley   +1 more source

Data from Natural Killer Cell Recruitment and Activation Are Regulated by CD47 Expression in the Tumor Microenvironment

, 2023
Pulak Ranjan Nath, Dipasmita Pal-Nath, Ajeet Mandal, Margaret C. Cam, Anthony L. Schwartz, David D. Roberts   +5 more
openalex   +1 more source